Correa-Valdez M

Language: Spanish
References: 10
Page: 192-194
PDF size: 748.86 Kb.

Text Extraction

No abstract.

REFERENCES

1. Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, etal. Cardiorenal syndrome: classification, pathophysiology, diagnosis,and treatment strategies: a scientific statement from the American HeartAssociation. Circulation. 2019;139:e840-e878.

2. House AA, Wanner C, Sarnak MJ. Chronic kidney disease andcardiovascular disease: epidemiology and management. Kidney Int.2024;105:1219-1230.

3. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO2024 Clinical practice guideline for the evaluation and management ofchronic kidney disease. Kidney Int. 2024;105:S117-S314. doi: 10.1016/j.kint.2023.10.018.

4. Thompson A, Fleischmann KE, Smilowitz NR, de Las Fuentes L,Mukherjee D, Aggarwal NR, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardiovascularmanagement for noncardiac surgery: a report of the American Collegeof Cardiology/American Heart Association Joint Committee on clinicalpractice guidelines. Circulation. 2024;150:e351-e442. doi: 10.1161/CIR.0000000000001285.

5. Cohn SL. 2024 ACC/AHA guideline on perioperative cardiovascularmanagement before noncardiac surgery: what’s new? Cleve Clin J Med.2025;92:213-219.

6. Palamuthusingam D, Pascoe EM, Hawley CM, Johnson DW, Fahim M.Revised cardiac risk index in predicting cardiovascular complicationsin patients receiving chronic kidney replacement therapy undergoingelective general surgery. Perioper Med (Lond). 2024;13:70.

7. deFilippi CR, Herzog CA. Interpreting cardiac troponin results in chronickidney disease. Circulation. 2023;63:59-65.

8. Matsushita K, Ballew SH, Coresh J. Cardiovascular risk predictionin people with chronic kidney disease. Curr Opin Nephrol Hypertens.2016;25:518-523.

9. Moscucci M, Eagle KA. Coronary revascularization before noncardiacsurgery. N Engl Med. 2004;351:2861-2863.

10. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation ofrenal disease in randomized controlled trials of cardiovascular disease.JAMA. 2006;296:1377-1384.